CONFIRM-2: Artificial Intelligence Enabled Quantitative CT Assessment of Atherosclerosis and Major Adverse Events: A Multi-Center International Registry-Clinical Conversation

Video Transcription

Video Summary

The Sky Conversations in Interventional Cardiology event, led by Jader Sandoval from the Minneapolis Heart Institute, focused on the CONFIRM-2 study. This multicenter research leverages AI in quantitative CT imaging to assess atherosclerosis and predict major adverse cardiovascular events. The study involved 3,500 patients from 18 international sites, focusing on non-calcified plaque burden and stenosis severity as key predictors. Dr. Alexander Van Rosendael highlighted the significance of AI in accurately measuring these factors, which contribute to better risk stratification and treatment planning. Discussion among experts like Dr. Mervet Alesnak, Dr. Omar Khaliq, and Dr. Evan Schlafly emphasized the merging of interventional cardiology and advanced imaging techniques, underscoring the potential to enhance preventative strategies and informed clinical decisions. The ongoing CONFIRM-2 aims to expand data for better understanding and application of these findings in clinical practice, ultimately improving patient outcomes.

Keywords

Interventional Cardiology

CONFIRM-2 Study

AI in CT Imaging

Atherosclerosis Assessment

Risk Stratification

Preventative Strategies